RE: Excitement building10 Sep 2024 08:52
Right bang up to date, here are all the very latest deals in our sector to get us all excited about what could unfold here for Sareum shareholders:
• Eli Lilly acquired Morphic, on August 16, 2024, for $3.2 billion. The deal was focused on Morphic’s main drug discovery candidate (MORF-057) for inflammatory bowel disease
• CVC Capital signed an agreement on 7th August to Therakos for $925 Million
• AbbVie completed its acquisition of Cerevel Therapeutics on August 2, for $8.7 billion
• Otsuka purchased Jnana Therapeutics on August 1, for $800 million
• MilliporeSigma acquired Mirus Bio on August 1, for $600 million
• Boehringer Ingelheim acquired Nerio Therapeutics Inc.for $1.3 Billion on July 29th
• Roche completed its acquisition of Carmot Therapeutics, a clinical-stage company on July 29, for $2.7 billion
• On July 24th Agilent Technologies signed a definitive agreement to acquire BioVectra, for $925 million
• Merck MSD purchased EyeBio on 12th July for up to $3 Billion.
• Thermo Fisher acquired Olink on July 10, for $3.1 billion
• On 24th June ANI Pharma acquired Alimera for $381 million
• June 12th saw Ono Pharmaceutical buy Deciphera Pharma for $2.4 billion
• Asahi Kasei bought Calliditas on May 28, 2024 for $1.1 billion
• Biogen bought HI-Bio, on May 22, for $1.15 billion upfront and up to $650 million in potential milestone payments
• J&J acquired Proteologix on May 16, for $850 million in cash
• Novartis agreed to acquire Mariana Oncology, a preclinical-stage biotechnology on May 3, for $1 billion upfront & a further $750 million in milestone payments
• Deciphera Pharma bought ONO Pharma on April 29, for $2.4 billion
• Incyte Corp acquired Escient Pharma, a clinical-stage drug discovery and development company, on April 23, for $750 million
• Eliem Therapeutics bought Tenet Medicines, another development-stage biotechnology company, on April 11th for $210 million
• Vertex Pharma acquired Alpine Sciences on April 11th for $4.9 billion
• CoreRx acquired Societal Inc (focused on small molecule therapeutics) on April 9 for $130 million
• J&J purchased Shockwave Medical on April 5, for $13.1 billion
• Genmab bought Profound Bio – which specialises in developing next generation treatments of certain cancers - on April 3, for $1.8 billion
• Bora Pharm bought Upsher Smith Bio on April 2,for $210 million
• On March 25th, Novo Nordisk agreed to acquire Cardior Pharmaceuticals for $1.12 billion
• AbbVie acquired Landos on March 25, for $137.5 million
• AZ bought Fusion Pharma on March 19, for $2.4 billion
• BMS acquired Karuna on March 18, for $14 billion
• AZ bought Amolyt, a clinical-stage company, on March 14
for $1.05 billion
• Novartis acquired IFM on March 13, for $90 million upfront plus up to $745 million in milestones
• Johnson & Johnson acquired Ambrx Biopharma Inc., a clinical-stage company on March 7,for $2 billion
• Gilead bought CymaBa
Sign In
Follow the stocks
